LOS ANGELES & NEW YORK--(BUSINESS WIRE)--
Houlihan Lokey (NYSE:HLI), the global investment bank, today announced
that it has appointed Jacqueline Kosecoff, Ph.D. to its Board of
Directors, (“Board”) as an independent director. The appointment is
effective immediately, and she will stand for election to the Board at
the 2016 annual meeting of shareholders. Dr. Kosecoff will serve on the
Audit Committee and the Nominating and Corporate Governance Committee.
With the addition, the Board expands to eleven members, three of whom
are independent.
“I am pleased to welcome Jacqueline to our board as an independent
director,” said Irwin N. Gold, Executive Chairman and Director of
Houlihan Lokey. “Her expertise, including experience serving on several
public company boards, will add a valuable perspective as we continue
building a global business. We look forward to benefiting from her
contributions.”
Dr. Kosecoff works in private equity as a Managing Partner of Moriah
Partners. She has been in this role since 2012.
From 2002 to 2012, Dr. Kosecoff was a senior executive with UnitedHealth
Group-PacifiCare. She joined UnitedHealth Group as part of its
acquisition of PacifiCare Health Systems in 2005. Prior to joining
UnitedHealth Group-PacifiCare, Dr. Kosecoff was founder, President and
Chief Operating Officer of Protocare, a firm whose lines of business
included the clinical development of drugs, devices, biopharmaceutical
and nutritional products, and health services consulting. Dr. Kosecoff
was also co-founder and Co-CEO of Value Health Sciences (VHS), a wholly
owned subsidiary of Value Health, Inc. (NYSE: VHI).
A seasoned member of corporate boards of directors, Dr. Kosecoff sits on
the boards of athenahealth, Inc. (NASDAQ: ATHN); Sealed Air Corporation
(NYSE: SEE); and, STERIS Corporation (NYSE: STE) and previously served
as a director of CareFusion Corporation.
Dr. Kosecoff holds a bachelor of arts degree from the University of
California, Los Angeles (UCLA), a master of science in applied
mathematics from Brown University, and a Ph.D. degree in research
methods from UCLA.
About Houlihan Lokey
Houlihan Lokey, Inc. (NYSE: HLI) is a global investment bank with
expertise in mergers and acquisitions, capital markets, valuation,
financial restructuring, and strategic consulting. The firm serves
corporations, institutions, and governments worldwide with offices in
the United States, Europe, and the Asia-Pacific region. Independent
advice and intellectual rigor are hallmarks of our commitment to client
success across our advisory services. Houlihan Lokey is ranked as the
No. 1 M&A advisor for all U.S. transactions, the No. 1 global M&A
fairness opinion advisor over the past 15 years, and the No. 1 global
restructuring advisor, according to Thomson Reuters. For more
information, please visit www.HL.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160620005570/en/
Houlihan Lokey
Investor Relations:
212-331-8225
ir@hl.com
or
Media
Relations:
212-331-8223
pr@hl.com
Source: Houlihan Lokey